Interventions with paclitaxel drug-coated balloons

This PCR statement on paclitaxel drug-coated balloons (DCB) usein peripheral interventions addresses the controversy raised by the meta-analysis of K.Katsanos, M.D., Ph.D. (Patras University Hospital, Rion, Greece) and colleagues, published in late2018.
Source: EurekaAlert, https://www.eurekalert.org